Thyroid cancer
Thyroid cancer is the most common thyroid malignancy. It is a malignancy originating from thyroid epithelial cells. Most thyroid cancers originate from follicular epithelial cells. According to the pathological type, it can be divided into papillary carcinoma (60%) and follicular adenocarcinoma (20%), but the prognosis is better; follicular adenocarcinoma grows faster, is moderately malignant, and is easy to metastasize through blood transport; undifferentiated carcinoma has a very poor prognosis, with an average survival time of 3 to 6 months. Papillary carcinoma is more common in clinical practice among thyroid cancers.
-
Site of disease:
thyroid -
Infectious :
Not contagious -
Frequent population:
Middle-aged and elderly people -
Related symptoms:
Thyroid nodules Painless hard nodules Submandibular lymphadenopathy and tenderness Lung metastasis Bone metastasis
Related Drugs
NIVA THYROID_- thyroid, porcine_tablet
Indication: Niva Thyroid tablets are indicated: 1. As replacement or supplemental therapy in patients with hypothyroidism of any etiology, except transient hypothyroidism during the recovery phase of subacute thyroiditis. This category includes cretinism, myxedema, and ordinary hypothyroidism in patients of any age (children, adults, the elderly), or state (including pregnancy); primary hypothyroidism resulting from functional deficiency, primary atrophy, partial or total absence of thyroid gland, or the effects of surgery, radiation, or drugs, with or without the presence of goiter; and secondary (pituitary), or tertiary (hypothalamic) hypothyroidism (See WARNINGS 2. As pituitary TSH suppressants, in the treatment or prevention of various types of euthyroid goiters, including thyroid nodules, subacute or chronic lymphocytic thyroiditis (Hashimoto’s), multinodular goiter, and in the management of thyroid cancer.
Manufacturer:
A-S Medication Solutions